Phase 4 Crohn's Disease and Colitis Trial, Not Yet Recruiting (NCT06794944)

Phase 4 Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT06794944 Sponsor: Brigham and Women's Hospital Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT06794944 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have agreed to take part and signed a consent form
You are male or female and over 18 years old
You have been diagnosed with Inflammatory Bowel Disease (IBD), which includes Crohn's disease, Ulcerative Colitis, or Indeterminate Colitis
You are already scheduled for an outpatient colonoscopy for any reason

Who may not be able to join:

You are not able to give your own consent to participate
You have previously had surgery to remove part or all of your colon, have a stoma (ostomy), a J-pouch, or any other prior colon surgery (having had your appendix removed is still allowed)
You are not able to complete all parts of the study as required
You regularly take antibiotics on an ongoing basis
You are unable or unwilling to swallow capsules
You have a known allergy or sensitivity to vancomycin, fidaxomicin, or microcrystalline cellulose (an ingredient sometimes found in capsules — confirm with trial site if unsure)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Jessica Allegretti, MD, MPH, Brigham and Women's Hospital

Phone: 6175257322

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06794944

Sponsor: Brigham and Women's Hospital

Phase: Phase 4

Status: Not Yet Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: 6175257322

More information: https://clinicaltrials.gov/study/NCT06794944

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have agreed to take part and signed a consent form
You are male or female and over 18 years old
You have been diagnosed with Inflammatory Bowel Disease (IBD), which includes Crohn's disease, Ulcerative Colitis, or Indeterminate Colitis
You are already scheduled for an outpatient colonoscopy for any reason

Who may not be able to join:

You are not able to give your own consent to participate
You have previously had surgery to remove part or all of your colon, have a stoma (ostomy), a J-pouch, or any other prior colon surgery (having had your appendix removed is still allowed)
You are not able to complete all parts of the study as required
You regularly take antibiotics on an ongoing basis
You are unable or unwilling to swallow capsules
You have a known allergy or sensitivity to vancomycin, fidaxomicin, or microcrystalline cellulose (an ingredient sometimes found in capsules — confirm with trial site if unsure)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Phase 4

Sponsor

Brigham and Women's Hospital

Registry

ClinicalTrials.gov

Start date

1 September 2026

Est. completion

1 September 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

C. difficile decolonization; Safety and tolerability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov